The extracellular concentration of the excitatory neurotransmitter glutamate is kept low by the action of glutamate transporters in the plasma membranes of both neurons and glial cells. These transporters may play important roles, not only in the adult brain, but also in the developing brain, as glutamate is thought to modulate the formation and elimination of synapses as well as neuronal migration, proliferation and apoptosis. Here we demonstrate the developmental changes in the expression of two glutamate transporters, GLAST and GLT, by quantitative immunoblotting and by light and electron microscopic immunocytochemistry. At birth, GLT is not detectable, but GLAST is present at significant concentrations both in the forebrain and in the cerebellum. GLT is first detected in the forebrain and cerebellum in the second and third week, respectively. Both transporters reach adult levels by postnatal week 5. The development of the total glutamate uptake activity in the forebrain, as determined by solubilization and reconstitution of the transporters in liposomes, parallels that of GLT, in agreement with the observation that GLT is the predominant transporter in the adult brain. The regional distributions of both GLAST and GLT in the tissue are similar in young and adult rats. Only GLAST is detectable in the external germinal layer of the cerebellar cortex. Electron microscopical investigation demonstrated GLAST and GLT exclusively in glial cells in young as well as in adult animals.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1460-9568.1997.tb01522.xDOI Listing

Publication Analysis

Top Keywords

glast glt
16
brain glutamate
8
glt
8
glutamate transporters
8
glial cells
8
adult brain
8
forebrain cerebellum
8
glutamate
6
glast
6
transporters
5

Similar Publications

Anxiety is a prominent non-motor symptom of Parkinson's disease (PD). Changes in the B-spectrum recordings in PD patients of the prefrontal cortex correlate with increased anxiety. Using a rodent model of PD, we reported alterations in glutamate synapses in the striatum and substantia nigra following dopamine (DA) loss.

View Article and Find Full Text PDF

The glutamatergic system, located throughout the brain including the prefrontal cortex and nucleus accumbens, plays a critical role in reward and reinforcement processing, and mediates the psychotropic effects of addictive drugs such as cocaine. Glutamate transporters, including EAAT2/GLT-1, are responsible for removing glutamate from the synaptic cleft. Reduced expression of GLT-1 following chronic cocaine use and abstinence has been reported.

View Article and Find Full Text PDF

Glutamate, the primary excitatory neurotransmitter in the CNS, is regulated by the excitatory amino acid transporters (EAATs) GLT-1 and GLAST. Following traumatic brain injury (TBI), extracellular glutamate levels increase, contributing to excitotoxicity, circuit dysfunction, and morbidity. Increased neuronal glutamate release and compromised astrocyte-mediated uptake contribute to elevated glutamate, but the mechanistic and spatiotemporal underpinnings of these changes are not well established.

View Article and Find Full Text PDF
Article Synopsis
  • * This study investigates the effects of different doses of leptin on cerebral ischemia-reperfusion injury in mice, assessing its neuroprotective capabilities after a simulated stroke event.
  • * Results indicated that leptin treatment improved neurological function, reduced brain damage, and altered the expression of certain proteins and glutamate levels, suggesting that leptin may protect the brain by mitigating excitotoxicity from excess glutamate.
View Article and Find Full Text PDF

NRICM101 prevents kainic acid-induced seizures in rats by modulating neuroinflammation and the glutamatergic system.

Int Immunopharmacol

October 2024

School of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan; Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan City 33303, Taiwan. Electronic address:

Article Synopsis
  • The study investigates the effects of the Traditional Chinese medicine formula NRICM101 on epilepsy, specifically its ability to reduce seizures induced by kainic acid (KA) in rats.
  • NRICM101 significantly decreases seizure behavior, neuronal loss, and glutamate levels while enhancing protective proteins in the brain, and its effects are comparable to the established antiseizure drug carbamazepine.
  • The formula also shows promising neuroprotective effects by mitigating inflammation and cell death in the brain without causing harm to the liver or kidneys, suggesting its potential for managing epilepsy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!